Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-face randomized double-blind comparison of platelet-rich fibrin with albumin with or without non-crosslinked hyaluronic acid for infraorbital aging
RBR-109q9s8hNot yet recruiting
- Sponsor
- Universidade Estadual de Montes Claros
- Start
- Oct 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of hyaluronic acid, platelet rich fibrin and albumin (human) in cutaneous aging (2 arms), sponsored by Universidade Estadual de Montes Claros. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
hyaluronic acidplatelet rich fibrinalbumin (human)
03
Conditions
cutaneous aging
Beyond the preview
Go deeper on RBR-109q9s8h.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-109q9s8h.